Physician profile
Mary E Crowther
NPI 1114998853
$898.06
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $60.13 · 2021: $400.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renovia INC | $237.95 | 2019-2021 | |
| Abbvie INC. | $175.53 | 2019-2021 | |
| Therapeuticsmd, INC. | $94.53 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.72 | 2019-2021 | |
| Pfizer INC. | $70.85 | 2019-2021 | |
| Coopersurgical, INC. | $41.49 | 2019-2021 | |
| Allergan, INC. | $36.64 | 2019 | |
| Avion Pharmaceuticals | $30.49 | 2021 | |
| Duchesnay USA Incorporated | $24.18 | 2019 | |
| Exeltis, USA INC. | $20.93 | 2021 | |
| Amag Pharmaceuticals, INC. | $18.62 | 2020 | |
| Daiichi Sankyo INC. | $18.31 | 2019 | |
| Merck Sharp & Dohme LLC | $16.72 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.93 | 2019 | |
| Sage Therapeutics, LLC | $14.17 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Crowther listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.